PHG
Koninklijke Philips N.V.
Set alert
- YTD
- -0.59%
- 1 year
- -1.28%
- Open
- 27.39
- Prev close
- 27.12
- Mkt cap
- 26.31B
- Vol
- 1.27M
- Avg vol
- 966.48K
- EPS
- 1.34
- P/E
- 20.09
- Div yield
- 3.74%
More statistics
- Low
- 26.87
- High
- 27.39
- Forward P/E
- 14.22
- Beta
- 0.92
- Short ratio
- 2.52
- Inst. own
- 5.39%
- Dividend
- 1.01
- Ex-div date
- May 12, 2026
- Earnings
- Nov 3, 2026
- 50-d avg
- 25.53
- 200-d avg
- 27.22
- 1y target
- 32.02
Key statistics
- Market cap
- 26.32B
- Enterprise value
- 32.21B
- Trailing P/E
- 20.10
- Forward P/E
- 14.22
- PEG ratio
- 0.84
- Price / sales
- 1.49
- Price / book
- 2.05
- EPS (TTM)
- 1.34
- Beta
- 0.92
- Dividend yield
- 3.74%
- Payout ratio
- 75.51%
- Profit margin
- 6.31%
- Revenue (TTM)
- 17.66B
- Revenue growth
- 0.50%
- Free cash flow
- 1.53B
- Total cash
- 1.79B
- Total debt
- 7.46B
- Return on equity
- 10.15%
- Shares outstanding
- 977.43M
- Short % of float
- 0.00%
- 50-day average
- 25.53
- 200-day average
- 27.22
Analyst view
Consensus: none
- Target (low)
- 26.20
- Target (mean)
- 32.02
- Target (high)
- 41.00
- Strong buy2
- Buy0
- Hold3
- Sell0
- Strong sell0
Next earnings
Nov 3, 2026
Expected Nov 3, 2026. Consensus EPS estimate 0.36005.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 3, 2026 | Sep 30, 2026 | 0.37 | — | — | — |
| Jul 27, 2026 | Jun 30, 2026 | 0.40 | 0.57 | +0.17 | +42.50% |
| May 6, 2026 | Mar 31, 2026 | 0.24 | 0.27 | +0.03 | +12.50% |
| Feb 10, 2026 | Dec 31, 2025 | 0.565 | 0.70 | +0.14 | +23.89% |
| Nov 4, 2025 | Sep 30, 2025 | 0.37 | 0.37 | 0.00 | 0.00% |
| Jul 29, 2025 | Jun 30, 2025 | 0.3174 | 0.41 | +0.09 | +29.17% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 3, 2026 | UBS | down | Buy | Neutral |
| Feb 20, 2025 | UBS | up | Neutral | Buy |
| Oct 29, 2024 | Jefferies | up | Underperform | Hold |
| May 13, 2024 | Bernstein | up | Market Perform | Outperform |
| Apr 30, 2024 | UBS | up | Sell | Neutral |
| Apr 30, 2024 | JP Morgan | up | Underweight | Neutral |
About Koninklijke Philips N.V.
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- Netherlands
- Website
- philips.com
News
- Philips launches HyperVue Integrated System in the U.S., bringing advanced coronary imaging and physiology into the cathlab
- Philips launches UniGuide 3D Live Guidance, bringing CT planning into live procedures and extending the capabilities of its Azurion image-guided therapy platform
- Philips identifies three beauty tech trends set to transform beauty routines into lasting relationships by 2027
- Philips And UMCG Launch Five-Year EXIT-CVD Project With 42 Partners In 17 Countries, 22 Clinical Studies Of 14,000+ Patients, EUR 27.6M Budget
- Royal Philips Receives ARPA Award Of Up To $33.7M Under the U.S. HHS Autonomous Interventions And Robotics Program
- Exor Deepens Philips Bet, Opens Door to 22% Stake
- Philips And Exor Renew Long-Term Agreement, Keeping Governance Unchanged While Raising Shareholding Flexibility To 22%
- Philips Stock Sinks To 52-Week Low - Here's Why
- Philips Reiterates 2026 Outlook, Raises Adjusted EBITA Margin To 13.5%-14.0% And Free Cash Flow To EUR 1.5B-1.7B On US Tariff Refund
- Koninklijke Philips Q2 Adj. EPS $0.57 Beats $0.40 Estimate, Sales $5.068B Beat $5.040B Estimate
Your note
Sign in to keep a note on PHG — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Exor N.V. | 18.92% | 185,932,684 | 5.01B | Jun 29, 2026 |
| Mondrian Investment Partners Ltd | 0.80% | 7,885,781 | 212.36M | Sep 29, 2026 |
| Dimensional Fund Advisors LP | 0.44% | 4,340,691 | 116.89M | Jun 29, 2026 |
| Fiduciary Management, Inc. | 0.35% | 3,459,961 | 93.18M | Jun 29, 2026 |
| Causeway Capital Management LLC | 0.31% | 3,061,962 | 82.46M | Jun 29, 2026 |
| Morgan Stanley | 0.30% | 2,935,662 | 79.06M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMI Funds Inc-Large Cap Fund | 0.12% | 1,215,000 | 32.72M | Jun 29, 2026 |
| Dimensional ETF Trust-Dimensional International Value ETF | 0.10% | 995,485 | 26.81M | Jul 30, 2026 |
| DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT. | 0.10% | 1,017,635 | 27.40M | Jul 30, 2026 |
| DFA INVESTMENT TRUST CO-The DFA International Value Series | 0.06% | 630,121 | 16.97M | Jul 30, 2026 |
| Liberty All Star Equity Fund | 0.05% | 454,135 | 12.23M | Jun 29, 2026 |
| Dimensional ETF Trust-Dimensional International Core Equity 2 ETF | 0.04% | 388,912 | 10.47M | Jul 30, 2026 |